ND SB2384 | 2023-2024 | 68th Legislative Assembly
Status
Spectrum: Partisan Bill (Republican 4-0)
Status: Engrossed on February 10 2023 - 50% progression
Action: 2023-04-04 - Second reading, failed to pass, yeas 38 nays 53
Text: Latest bill text (Engrossed) [PDF]
Status: Engrossed on February 10 2023 - 50% progression
Action: 2023-04-04 - Second reading, failed to pass, yeas 38 nays 53
Text: Latest bill text (Engrossed) [PDF]
Summary
A BILL for an Act to provide for a legislative management study relating to vaccines for respiratory syncytial virus and vaccines developed using messenger ribonucleic acid technology.
Title
A BILL for an Act to provide for a legislative management study relating to vaccines for respiratory syncytial virus and vaccines developed using messenger ribonucleic acid technology.
Sponsors
Roll Calls
2023-04-04 - House - House Second reading (Y: 38 N: 53 NV: 0 Abs: 3) [FAIL]
2023-02-09 - Senate - Senate Second reading (Y: 25 N: 22 NV: 0 Abs: 0) [PASS]
2023-02-09 - Senate - Senate Second reading (Y: 25 N: 22 NV: 0 Abs: 0) [PASS]
History
| Date | Chamber | Action |
|---|---|---|
| 2023-04-04 | House | Second reading, failed to pass, yeas 38 nays 53 |
| 2023-04-03 | House | Reported back, do not pass, placed on calendar 7 6 1 |
| 2023-03-15 | House | Committee Hearing 02:30 |
| 2023-02-17 | House | Introduced, first reading, referred to Human Services |
| 2023-02-10 | House | Received from Senate |
| 2023-02-09 | Senate | Second reading, passed, yeas 25 nays 22 |
| 2023-02-09 | Senate | Amendment adopted |
| 2023-02-09 | Senate | Amendment proposed on floor |
| 2023-02-09 | Senate | Reported back, do not pass, placed on calendar 6 0 0 |
| 2023-02-08 | Senate | Committee Hearing 03:44 |
| 2023-02-07 | Senate | Committee Hearing 09:30 |
| 2023-01-23 | Senate | Introduced, first reading, referred to Human Services |
